Peptide Receptor Radionuclide Therapy in Patients With Advanced Progressive Medullary Thyroid Cancer: Efficacy, Safety, and Survival Predictors.

Qingxing Liu,Harshad R Kulkarni,Tianzhi Zhao,Christiane Schuchardt,Xiaoyuan Chen,Zhaohui Zhu,Jingjing Zhang,Richard P Baum

Clinical nuclear medicine（2023）

引用 2|浏览21

暂无评分

摘要

Peptide receptor radionuclide therapy was well tolerated and effective in patients with advanced, aggressive MTC. Bone metastasis was an independent adverse prognostic factor for OS.

查看译文

关键词

Lu-177,Y-90,medullary thyroid cancer,peptide receptor radionuclide therapy,safety,survival

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要